Market Overview

Roth Capital Initiates ContraFect At Buy


Analysts at Roth Capital initiated coverage on shares of ContraFect (NASDAQ: CFRX) with a Buy rating.

The target price for ContraFect is set to $14.

ContraFect's shares rose 4.53% to close at $3.46 on Friday.

Latest Ratings for CFRX

Jun 2018Initiates Coverage OnBuy
Sep 2016Initiates Coverage onOutperform
Jul 2016Initiates Coverage onOverweight

View More Analyst Ratings for CFRX
View the Latest Analyst Ratings

Posted-In: Roth CapitalInitiation Analyst Ratings


Related Articles (CFRX)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

A Technical Look At Hewlett-Packard Company

Morgan Stanley Downgrades Fortinet To Equal-weight